Valcreate Life Sciences and Speciality Opportunities PMS
Dedicated Pharma and Speciality Chemicals Strategy
Pharma sector is a significant long-term value creator
- Large macro growth potential: significant proportion of branded medicines globally going generic
- India opportunity: global leader in supplying low-cost & high quality medicines. Large pool of low-cost talent.
- Defensive nature: Business model is relatively insulated from economic cycles.
Strong Long-term Value Creation
Over FY08-FY22, INR 1cr invested in the BSE
Healthcare Index would be worth Rs.
5.2 cr vs. 3 cr for a similar investment in the Sensex.
Acts as a strong defensive play in weak markets
- Non-Discretionary Spends: patient’s healthcare spends are not dependent on the economy/sentiment
- Beneficiary of Rupee Depreciation: economic downturns are typically linked with a weak rupee
- Strong Balance Sheets: Strong free cash generation, balance sheets and margins
Chemicals
Speciality Chemicals - Focusing on Value Chains
Agrochemicals is a 2 faced Opportunity
Economy Agnostic
Aligned to pharma and agrochemicals industry which are more economy agnostic.
Key characteristics that make multibaggers in pharma
- Promoters: Technocrat Promoters, Corporate Governance and Capabilities
- Product Portfolio: Factors such as Generics, Speciality, Low Competition, Complex products dictate Sustainable Profitability
- Target Markets: Large Innovators, Generics, Tender Markets, Branded Markets, Branded Generics being Catered to
- Market Share: High Share in Leading Products
- Pipeline: Large Filing Pipeline, Pending Approvals, Launch Opportunity and R&D Focus
Our Track Record Speaks for Itself
- Life Sciences and Speciality Opportunities Strategy has given 18% CAGR vs 14% of Benchmark between inception to mid-2021
- Within just 2 years of existence, Valcreate Strategies delivered Leading Performance
- For most months in 2020, Life Sciences Strategy was the number 1 Performing Strategy, especially during Market Crash (as per PMS Bazaar)
- Many of the Picks are Multi-baggers in the Portfolio
- Avoiding Big Mistake is the Pillar
